Modifying superparamagnetic iron oxides nanoparticles for doxorubicin delivery carriers: a review

1.

Senkus E, Jassem J (2011) Cardiovascular effects of systemic cancer treatment. Cancer Treat Rev 37(4):300–311CrossRef

2.

Kucharska W, Negrusz-Kawecka M, Gromkowska M (2012) Cardiotoxicity of oncological treatment in children. Adv Clin Exp Med 21(3):281–288

3.

Doan L, Lu Y, Karatela M et al (2019) Surface modifications of superparamagnetic iron oxide nanoparticles with polylactic acid-polyethylene glycol diblock copolymer and graphene oxide for a protein delivery vehicle. Engineered Science (7):10–16. https://doi.org/10.30919/es8d510

4.

Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP–dependent transporters. Nat Rev Cancer 2(1):48–58CrossRef

5.

Jin S, Ye K (2013) Targeted drug delivery for breast cancer treatment. Recent Pat Anticancer Drug Discov 8(2):143–153CrossRef

6.

Minotti G, Saponiero A, Licata S et al (2001) Paclitaxel and docetaxel enhance the metabolism of doxorubicin to toxic species in human myocardium. Clin Cancer Res 7(6):1511–1515

7.

Kalyanaraman B (2020) Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: have we been barking up the wrong tree? Redox Biol 29:101394CrossRef

8.

Hoke EM, Maylock CA, Shacter E (2005) Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin. Free Radical Biol Med 39(3):403–411CrossRef

9.

Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems: Doxorubicin cell and molecular biological activity. J Pharm Pharmacol 65(2):157–170CrossRef

10.

Hanušová V, Boušová I, Skálová L (2011) Possibilities to increase the effectiveness of doxorubicin in cancer cells killing. Drug Metab Rev 43(4):540–557CrossRef

11.

Gewirtz DA (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57(7):727–741CrossRef

12.

Carvalho C, Santos RX, Cardoso S et al (2009) Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 16(25):3267–3285CrossRef

13.

Binaschi M, Bigioni M, Cipollone A et al (2001) Anthracyclines: selected new developments. Curr Med Chem Anticancer Agents 1(2):113–130CrossRef

14.

Arpino G, Ciocca DR, Weiss H et al (2005) Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer. Breast Cancer Res Treat 92(1):69–75CrossRef

15.

Bertheau P, Plassa F, Espié M et al (2002) Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy. Lancet 360(9336):852–854CrossRef

16.

Clementi ME, Giardina B, Di Stasio E et al (2003) Doxorubicin-derived metabolites induce release of cytochrome C and inhibition of respiration on cardiac isolated mitochondria. Anticancer Res 23(3B):2445–2450

17.

Di Leo A, Isola J (2003) Topoisomerase II alpha as a marker predicting the efficacy of anthracyclines in breast cancer: are we at the end of the beginning? Clin Breast Cancer 4(3):179–186

18.

Doroshow JH (1986) Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents. Biochem Biophys Res Commun 135(1):330–335CrossRef

19.

Dunkern TR, Wedemeyer I, Baumgärtner M et al (2003) Resistance of p53 knockout cells to doxorubicin is related to reduced formation of DNA strand breaks rather than impaired apoptotic signaling. DNA Repair 2(1):49–60CrossRef

20.

Green PS, Leeuwenburgh C (2002) Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis. Biochim Biophys Acta 1588(1):94–101CrossRef

21.

Guano F, Pourquier P, Tinelli S et al (1999) Topoisomerase poisoning activity of novel disaccharide anthracyclines. Mol Pharmacol 56(1):77–84CrossRef

22.

Inoue A, Narumi K, Matsubara N et al (2000) Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene. Cancer Lett 157(1):105–112CrossRef

23.

Lage H, Dietel M (2002) Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells. J Cancer Res Clin Oncol 128(7):349–357CrossRef

24.

Lage H, Helmbach H, Dietel M et al (2000) Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance. Br J Cancer 82(2):488–491CrossRef

25.

MacGrogan G, Rudolph P, de Mascarel Id I et al (2003) DNA topoisomerase IIalpha expression and the response toprimary chemotherapy in breast cancer. Br J Cancer 89(4):666–671CrossRef

26.

Penault-Llorca F, Cayre A, Bouchet Mishellany F et al (2003) Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome. Int J Oncol 22(6):1319–1325

27.

Perego P, Corna E, De Cesare M et al (2001) Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines. Curr Med Chem 8(1):31–37CrossRef

28.

Ramachandran C, Samy TS, Huang XL et al (1993) Doxorubicin-induced DNA breaks, topoisomerase II activity and gene expression in human melanoma cells. Biochem Pharmacol 45(6):1367–1371CrossRef

29.

Ruiz-Ruiz C, Robledo G, Cano E et al (2003) Characterization of p53-mediated up-regulation of CD95 gene expression upon genotoxic treatment in human breast tumor cells. J Biol Chem 278(34):31667–31675CrossRef

30.

Sinha BK, Katki AG, Batist G et al (1987) Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells. Biochem Pharmacol 36(6):793–796CrossRef

31.

Stearns V, Singh B, Tsangaris T et al (2003) A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer. Clin Cancer Res 9(1):124–133

32.

Lipshultz SE, Lipsitz SR, Sallan SE et al (2005) Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. JCO 23(12):2629–2636CrossRef

33.

Iarussi D, Indolfi P, Casale F et al (2005) Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management. Pediatr Drugs 7(2):67–76CrossRef

34.

Sorensen K, Levitt GA, Bull C et al (2003) Late anthracycline cardiotoxicity after childhood cancer. Cancer 97(8):1991–1998CrossRef

35.

Doyle JJ, Neugut AI, Jacobson JS et al (2005) Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. JCO 23(34):8597–8605CrossRef

36.

Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 339(13):900–905CrossRef

37.

Chlebowski RT (1979) Adriamycin (doxorubicin) cardiotoxicity: a review. West J Med 131(5):364–368

38.

Bristow MR, Billingham ME, Mason JW et al (1978) Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep 62(6):873–879

39.

Zhao X, Zhang J, Tong N et al (2012) Protective effects of berberine on doxorubicin-induced hepatotoxicity in mice. Biol Pharm Bull 35(5):796–800CrossRef

40.

Jacevic V, Djordjevic A, Srdjenovic B et al (2017) Fullerenol nanoparticles prevents doxorubicin-induced acute hepatotoxicity in rats. Exp Mol Pathol 102(2):360–369CrossRef

41.

Pugazhendhi A, Edison TNJI, Velmurugan BK et al (2018) Toxicity of Doxorubicin (Dox) to different experimental organ systems. Life Sci 200:26–30CrossRef

42.

Nowara E, Huszno J (2013) Skin toxicity after palliative chemotherapy containing pegylated liposomal doxorubicin for ovarian cancer patients. Ann Palliat Med 2(2):71–75

43.

Siswanto S, Arozal W, Juniantito V et al (2016) The effect of mangiferin against brain damage caused by oxidative stress and inflammation induced by doxorubicin. HAYATI J Biosci 23(2):51–55CrossRef

44.

Tangpong J, Miriyala S, Noel T et al (2011) Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia Mangostana. Neuroscience 175:292–299CrossRef

45.

Su Z, Ye J, Qin Z et al (2016) Protective effects of madecassoside against Doxorubicin induced nephrotoxicity in vivo and in vitro. Sci Rep 5(1):18314CrossRef

46.

Kim DR, Lee SY, Kim JS et al (2017) Ameliorating effect of gemigliptin on renal injury in murine adriamycin-induced nephropathy. Biomed Res Int 2017:1–10

47.

Kabel AM (2018) Zinc/alogliptin combination attenuates testicular toxicity induced by doxorubicin in rats: role of oxidative stress, apoptosis and TGF-β1/NF-κB signaling. Biomed Pharmacother 97:439–449CrossRef

48.

Leonard RCF, Williams S, Tulpule A et al (2009) Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet™). The Breast 18(4):218–224CrossRef

49.

Strebhardt K, Ullrich A (2008) Paul Ehrlich’s magic bullet concept: 100 years of progress. Nat Rev Cancer 8(6):473–480CrossRef

50.

Vallet-Regí M, Balas F, Arcos D (2007) Mesoporous materials for drug delivery. Angew Chem Int Ed 46(40):7548–7558CrossRef

51.

Biju V (2014) Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy. Chem Soc Rev 43(3):744–764CrossRef

52.

Kohzadi S, Najmoddin N, Baharifar H et al (2022) Functionalized SPION immobilized on graphene-oxide: anticancer and antiviral study. Diam Relat Mater 127:109149CrossRef

53.

Jeng HA, Swanson J (2006) Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Health, Part A 41(12):2699–2711CrossRef

54.

Hussain SM, Hess KL, Gearhart JM et al (2005) In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19(7):975–983CrossRef

55.

Kim JS, Yoon TJ, Yu KN et al (2006) Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci 89(1):338–347CrossRef

56.

Karlsson HL, Gustafsson J, Cronholm P et al (2009) Size-dependent toxicity of metal oxide particles—a comparison between nano- and micrometer size. Toxicol Lett 188(2):112–118CrossRef

57.

Ma H-L, Qi XR, Maitani Y et al (2007) Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. Int J Pharm 333(1):177–186CrossRef

58.

Rahmani R, Gharanfoli M, Gholamin M et al (2020) Plant-mediated synthesis of superparamagnetic iron oxide nanoparticles (SPIONs) using aloe vera and flaxseed extracts and evaluation of their cellular toxicities. Ceram Int 46(3):3051–3058CrossRef

59.

Singh N, Jenkins GJS, Asadi R et al (2010) Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Reviews 1(1):5358CrossRef

60.

Gao S, Wu C, Jiang H et al (2014) Size-controlled porous superparamagnetic Zn1/3Fe8/3O4 nanospheres: synthesis, properties and application for drug delivery. RSC Advances 4:20841–20846CrossRef

61.

Min KA, Shin MC, Yu F et al (2013) Pulsed magnetic field improves the transport of iron oxide nanoparticles through cell barriers. ACS Nano 7(3):2161–2171CrossRef

62.

Min KA, Yu F, Yang VC et al (2010) Transcellular transport of heparin-coated magnetic iron oxide nanoparticles (Hep-MION) under the influence of an applied magnetic field. Pharmaceutics 2(2):119–135CrossRef

63.

Domenech M, Marrero-Berrios I, Torres-Lugo M et al (2013) Lysosomal membrane permeabilization by targeted magnetic nanoparticles in alternating magnetic fields. ACS Nano 7(6):5091–5101CrossRef

64.

Alexiou C, Arnold W, Klein RJ et al (2000) Locoregional cancer treatment with magnetic drug targeting. Cancer Res 60(23):6641–6648

65.

Alexiou C, Schmid RJ, Jurgons R et al (2006) Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur Biophys J 35(5):446–450CrossRef

66.

Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021CrossRef

67.

Pankhurst QA, Connolly J, Jones SK et al (2003) Applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys 36(13):R167–R181CrossRef

68.

Lübbe AS, Alexiou C, Bergemann C (2001) Clinical applications of magnetic drug targeting. J Surg Res 95(2):200–206CrossRef

69.

Lübbe AS, Bergemann C, Riess H et al (1996) Clinical experiences with magnetic drug targeting: a phase I study with 4’-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 56(20):4686–4693

70.

Mura S, Nicolas J, Couvreur P (2013) Stimuli-responsive nanocarriers for drug delivery. Nature Mater 12(11):991–1003CrossRef

71.

Tassa C, Shaw SY, Weissleder R (2011) Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res 44(10):842–852CrossRef

72.

Curcio A, Marotta R, Riedinger A et al (2012) Magnetic pH-responsive nanogels as multifunctional delivery tools for small interfering RNA (siRNA) molecules and iron oxide nanoparticles (IONPs). Chem Commun 48(18):2400CrossRef

73.

Yu MK, Jeong YY, Park J et al (2008) Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew Chem Int Ed 47(29):5362–5365CrossRef

74.

Sanson C, Diou O, Thévenot J et al (2011) Doxorubicin loaded magnetic polymersomes: theranostic nanocarriers for MR imaging and magneto-chemotherapy. ACS Nano 5(2):1122–1140CrossRef

75.

Amstad E, Kohlbrecher J, Müller E et al (2011) Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes. Nano Lett 11(4):1664–1670CrossRef

76.

Gupta AK, Naregalkar RR, Vaidya VD et al (2007) Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2(1):23–39CrossRef

77.

Gupta AK, Gupta M (2005) Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26(13):1565–1573CrossRef

78.

Duguet E, Vasseur S, Mornet S et al (2006) Magnetic nanoparticles and their applications in medicine. Nanomedicine 1(2):157–168CrossRef

79.

Gurzau ES, Neagu C, Gurzau AE (2003) Essential metals—case study on iron. Ecotoxicol Environ Saf 56(1):190–200CrossRef

80.

Elias A, Tourkas A (2009) Imaging circulating cells and lymphoid tissues with iron oxide nanoparticles. Hematology 1:720–726CrossRef

81.

Veranth JM, Kaser EG, Veranth MM et al (2007) Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts. Part Fibre Toxicol 4(1):2CrossRef

82.

Häfeli UO, Riffle JS, Harris-Shekhawat L et al (2009) Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharmaceutics 6(5):1417–1428CrossRef

83.

Stroh A, Zimmer C, Gutzeit C et al (2004) Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radical Biol Med 36(8):976–984CrossRef

84.

Sadeghiani N, Barbosa LS, Silva LP et al (2005) Genotoxicity and inflammatory investigation in mice treated with magnetite nanoparticles surface coated with polyaspartic acid. J Magn Magn Mater 289:466–468CrossRef

85.

Ejderyan N, Sanyal R, Sanyal A (2022) Stimuli-responsive polymer-coated iron oxide nanoparticles as drug delivery platforms. In Stimuli-responsive nanocarriers 133–169

86.

Basuki JS, Jacquemin A, Esser L et al (2014) A block copolymer-stabilized co-precipitation approach to magnetic iron oxide nanoparticles for potential use as MRI contrast agents. Polym Chem 5(7):2611–2620CrossRef

87.

Herranz F, Salinas B, Groult H et al (2014) Superparamagnetic nanoparticles for atherosclerosis imaging. Nanomaterials 4(2):408–438CrossRef

88.

Jensen KMØ, Andersen HL, Tyrsted C et al (2014) Mechanisms for iron oxide formation under hydrothermal conditions: an in situ total scattering study. ACS Nano 8(10):10704–10714CrossRef

89.

Kurzhals S, Zirbs R, Reimhult E (2015) Synthesis and magneto-thermal actuation of iron oxide core–PNIPAM shell nanoparticles. ACS Appl Mater Interfaces 7(34):19342–19352CrossRef

90.

Chin AB, Yaacob II (2007) Synthesis and characterization of magnetic iron oxide nanoparticles via w/o microemulsion and Massart’s procedure. J Mater Process Technol 191(1):235–237CrossRef

91.

Wang J, Sun J, Sun Q et al (2003) One-step hydrothermal process to prepare highly crystalline Fe3O4 nanoparticles with improved magnetic properties. Mater Res Bull 38(7):1113–1118CrossRef

92.

Mao B, Kang Z, Wang E et al (2006) Synthesis of magnetite octahedrons from iron powders through a mild hydrothermal method. Mater Res Bull 41(12):2226–2231CrossRef

93.

Sun S, Zeng H (2002) Size-controlled synthesis of magnetite nanoparticles. J Am Chem Soc 124(28):8204–8205CrossRef

94.

Lassenberger A, Grünewald TA, van Oostrum PDJ et al (2017) Monodisperse iron oxide nanoparticles by thermal decomposition: elucidating particle formation by second-resolved in situ small-angle X-ray scattering. Chem Mater 29(10):4511–4522CrossRef

95.

Park J, An K, Hwang Y et al (2004) Ultra-large-scale syntheses of monodisperse nanocrystals. Nature Mater 3(12):891–895CrossRef

96.

Guardia P, Pérez-Juste J, Labarta A et al (2010) Heating rate influence on the synthesis of iron oxide nanoparticles: the case of decanoic acid. Chem Commun 46(33):6108–6110CrossRef

97.

Riaz S, Bashir M, Naseem S (2014) Iron oxide nanoparticles prepared by modified co-precipitation method. IEEE Trans Magn 50(1):1–4

98.

Kang YS, Risbud S, Rabolt JF et al (1996) Synthesis and characterization of nanometer-size Fe ₃ O ₄ and γ-Fe ₂ O ₃ particles. Chem Mater 8(9):2209–2211CrossRef

99.

Bruce IJ, Taylor J, Todd M et al (2004) Synthesis, characterisation and application of silica-magnetite nanocomposites. J Magn Magn Mater 284:145–160CrossRef

100.

Laurent S, Forge D, Port M et al (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108(6):2064–2110CrossRef

101.

Gupta AK, Curtis ASG (2004) Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. Biomaterials 25(15):3029–3040CrossRef

102.

Kim DK, Zhang Y, Voit W et al (2001) Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles. J Magn Magn Mater 225(1–2):30–36CrossRef

103.

Marinin A (2012) Synthesis and characterization of superparamagnetic iron oxide nanoparticles coated with silica [Internet] [Master Thesis]. [Stockholm]: Royal Institute of Technology

104.

Muthiah M, Park IK, Cho CS (2013) Surface modification of iron oxide nanoparticles by biocompatible polymers for tissue imaging and targeting. Biotechnol Adv 31(8):1224–1236CrossRef

105.

Gribanov NM, Bibik EE, Buzunov OV et al (1990) Physico-chemical regularities of obtaining highly dispersed magnetite by the method of chemical condensation. J Magn Magn Mater 85(1–3):7–10CrossRef

106.

Massart R, Cabuil VJ (1987) Chim Phys Phys-Chim Biol 84:967–973CrossRef

107.

Karbarz M, Dagdelen S, Mackiewicz M et al (2023) Redox-responsive degradable microgel modified with superparamagnetic nanoparticles exhibiting controlled, hyperthermia-enhanced drug release. J Mater Sci 58:4094–4114CrossRef

108.

Noh K, Uthaman S, Lee CS et al (2022) Tumor intracellular microenvironment-responsive nanoparticles for magnetically targeted chemotherapy. J Ind Eng Chem 111:121–128CrossRef

109.

Nguyen MP, Kim Y, Ryu D et al (2022) Targeted chemotherapy based on amplifying the reactive oxygen species of doxorubicin-loaded polyaspartamide-encapsulated iron oxide nanoparticles. ACS Appl Nano Mater 5(5):7619–7631CrossRef

110.

Hadjipanayis GC, Siegel RW, editors (1994 [cited 2019 May 6].) Nanophase Materials [Internet]. Dordrecht: Springer Netherlands; Available from: https://doi.org/10.1007/978-94-011-1076-1

111.

Sjøgren CE, Briley-Saebø K, Hanson M et al (1994) Magnetic characterization of iron oxides for magnetic resonance imaging. Magn Reson Med 31(3):268–272CrossRef

112.

Babes L, Denizot B, Tanguy G et al (1999) Synthesis of iron oxide nanoparticles used as MRI contrast agents: a parametric study. J Colloid Interface Sci 212(2):474–482CrossRef

113.

Tartaj P, Morales MP, Veintemillas-Verdaguer S et al (2006) Synthesis, properties and biomedical applications of magnetic nanoparticles. Handbook of magnetic materials 16(5):403–482

114.

Hyeon T, Lee SS, Park J et al (2001) Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chem Soc 123(51):12798–12801CrossRef

115.

Chen D, Xu R (1998) Hydrothermal synthesis and characterization of nanocrystalline Fe3O4 powders. Mater Res Bull 33(7):1015–1021CrossRef

116.

Sato S, Murakata T, Yanagi H et al (1994) Hydrothermal synthesis of fine perovskite PbTiO3 powders with a simple mode of size distribution. J Mater Sci 29(21):5657–5663CrossRef

117.

Park J, Lee E, Hwang NM et al (2005) One-nanometer-scale size-controlled synthesis of monodisperse magnetic iron oxide nanoparticles. Angew Chem Int Ed 44(19):2872–2877CrossRef

118.

Dai Z, Meiser F, Möhwald H (2005) Nanoengineering of iron oxide and iron oxide/silica hollow spheres by sequential layering combined with a sol–gel process. J Colloid Interface Sci 288(1):298–300CrossRef

119.

Durães L, Costa BFO, Vasques J et al (2005) Phase investigation of as-prepared iron oxide/hydroxide produced by sol–gel synthesis. Mater Lett 59(7):859–863CrossRef

120.

Ismail AA (2005) Synthesis and characterization of Y2O3/Fe2O3/TiO2 nanoparticles by sol–gel method. Appl Catal B 58(1):115–121CrossRef

121.

Liu XQ, Tao SW, Shen YS (1997) Preparation and characterization of nanocrystalline α-Fe2O3 by a sol-gel process. Sens Actuators, B Chem 40(2):161–165CrossRef

122.

Kojima K, Miyazaki M, Mizukami F et al (1997) Selective formation of spinel iron oxide in thin films by complexing agent-assisted sol-gel processing. J Sol-Gel Sci Technol 8(1):77–81CrossRef

123.

Cannas C, Gatteschi D, Musinu A et al (1998) Structural and magnetic properties of Fe2O3 nanoparticles dispersed over a silica matrix. J Phys Chem B 102(40):7721–7726CrossRef

124.

Ennas G, Musinu A, Piccaluga G et al (1998) Characterization of iron oxide nanoparticles in an Fe2O3−SiO2 composite prepared by a sol−gel method. Chem Mater 10(2):495–502CrossRef

125.

da Costa GM, De Grave E, de Bakker PMA et al (1994) Synthesis and characterization of some iron oxides by sol-gel method. J Solid State Chem 113(2):405–412CrossRef

126.

del Monte F, Morales MP, Levy D et al (1997) Formation of γ-Fe2O3 isolated nanoparticles in a silica matrix. Langmuir 13(14):3627–3634CrossRef

127.

Chanéac C, Tronc E, Jolivet JP (1995) Thermal behavior of spinel iron oxide-silica composites. Nanostruct Mater 6(5):715–718CrossRef

128.

Niznansky D, Rehspringer JL, Drillon M (1994) Preparation of magnetic nanoparticles (/spl gamma/-Fe/sub 2/O/sub 3/) in the silica matrix. IEEE Trans Magn 30(2):821–823CrossRef

129.

Bentivegna F, Nyvlt M, Ferré J et al (1999) Magnetically textured γ-Fe2O3 nanoparticles in a silica gel matrix: optical and magneto-optical properties. J Appl Phys 85(4):2270–2278CrossRef

130.

Solinas S, Piccaluga G, Morales MP et al (2001) Sol-gel formation of γ-Fe2O3/SiO2 nanocomposites. Acta Mater 49(14):2805–2811CrossRef

131.

Fievet F, Lagier JP, Blin B et al (1989) Homogeneous and heterogeneous nucleations in the polyol process for the preparation of micron and submicron size metal particles. Solid State Ionics 32–33:198–205CrossRef

132.

Tzitzios VK, Petridis D, Zafiropoulou I et al (2005) Synthesis and characterization of L10 FePt nanoparticles from Pt–Fe3O4 core-shell nanoparticles. J Magn Magn Mater 294(2):e95–e98CrossRef

133.

Chow GM, Kurihara LK, Kemner KM et al (1995) Structural, morphological, and magnetic study of nanocrystalline cobalt-copper powders synthesized by the polyol process. J Mater Res 10(6):1546–1554CrossRef

134.

Viau G, Ravel F, Acher O et al (1994) Preparation and microwave characterization of spherical and monodisperse Co20Ni80 particles. J Appl Phys 76(10):6570–6572CrossRef

135.

Viau G, Ravel F, Acher O et al (1995) Preparation and microwave characterization of spherical and monodisperse Co20Ni80 particles. J Magn Magn Mater 140–144:377–378CrossRef

136.

Viau G, Fiévet-Vincent F, Fiévet F (1996) Monodisperse iron-based particles: precipitation in liquid polyols. J Mater Chem 6(6):1047–1053CrossRef

137.

Viau G, Fiévet-Vincent F, Fiévet F (1996) Nucleation and growth of bimetallic CoNi and FeNi monodisperse particles prepared in polyols. Solid State Ionics 84(3):259–270CrossRef

138.

Viau G, Fiévet-Vincent F, Fiévet F et al (1997) Size dependence of microwave permeability of spherical ferromagnetic particles. J Appl Phys 81(6):2749–2754CrossRef

139.

Toneguzzo Ph, Acher O, Viau G et al (1997) Observations of exchange resonance modes on submicrometer sized ferromagnetic particles. J Appl Phys 81(8):5546–5548CrossRef

140.

Toneguzzo P, Viau G, Acher O et al (1998) Monodisperse ferromagnetic particles for microwave applications. Adv Mater 10(13):1032–1035CrossRef

141.

Toneguzzo P, Acher O, Viau G et al (1999) Static and dynamic magnetic properties of fine CoNi and FeCoNi particles synthesized by the polyol process. IEEE Trans Magn 35(5):3469–3471CrossRef

142.

Yu S, Chow GM (2006) Synthesis of monodisperse iron oxide and iron/iron oxide core/shell nanoparticles via iron-oleylamine complex. J Nanosci Nanotechnol 6(7):2135–2140CrossRef

143.

Hegde MS, Larcher D, Dupont L et al (1996) Synthesis and chemical reactivity of polyol prepared monodisperse nickel powders. Solid State Ionics 93(1):33–50CrossRef

144.

Saravanan P, Jose TA, Thomas PJ et al (2001) Submicron particles of Co, Ni and Co-Ni alloys. Bull Mater Sci 24(5):515–521CrossRef

145.

Jungk HO, Feldmann C (2000) Nonagglomerated, submicron α–Fe2O3 particles: preparation and application. J Mater Res 15(10):2244–2248CrossRef

146.

Feldmann C (2001) Preparation of nanoscale pigment particles. Adv Mater 13(17):1301–1303CrossRef

147.

Bianco A, Gusmano G, Montanari R et al (1994) Preparation of Ni Co metal powders by co-reduction of Ni (II) and Co(II) hydroxides for magnetoresistive sensors. Mater Lett 19(5):263–268CrossRef

148.

Bianco A, Gusmano G, Montanari R et al (1995) Microstructural characterisation of Ni, Co and Ni Co fine powders for physical sensors. Thermochim Acta 269–270:117–132CrossRef

149.

Kurihara LK, Chow GM, Schoen PE (1995) Nanocrystalline metallic powders and films produced by the polyol method. Nanostruct Mater 5(6):607–613CrossRef

150.

Ammar S, Helfen A, Jouini N et al (2001) Magnetic properties of ultrafine cobalt ferrite particles synthesized by hydrolysis in a polyol mediumBasis of a presentation given at Materials Discussion No. 3, 26–29 September, 2000, University of Cambridge. UK. J Mater Chem 11(1):186–92CrossRef

151.

Yu W, Wang Y, Liu H et al (1996) Preparation and characterization of polymer-protected PtCo bimetallic colloids and their catalytic properties in the selective hydrogenation of cinnamaldehyde. J Mol Catal A: Chem 112(1):105–113CrossRef

152.

Kooli F, Rives V, Jones W (1997) Reduction of Ni2+−Al3+ and Cu2+−Al3+ layered double hydroxides to metallic Ni0 and Cu0 via polyol treatment. Chem Mater 9(10):2231–2235CrossRef

153.

Yamaguchi T, Kitajima K (1998) Reduction of interlayer Co2+ ions in fluorine mica using diethylene glycol. J Mater Sci 33(3):653–657CrossRef

154.

Toneguzzo Ph, Viau G, Acher O et al (2000) CoNi and FeCoNi fine particles prepared by the polyol process: physico-chemical characterization and dynamic magnetic properties. J Mater Sci 35(15):3767–3784CrossRef

155.

Poul L, Jouini N, Fiévet F (2000) Layered hydroxide metal acetates (metal = zinc, cobalt, and nickel): elaboration via hydrolysis in polyol medium and comparative study. Chem Mater 12(10):3123–3132CrossRef

156.

Wu M, He H, Zhao Z et al (2000) Preparation of magnetic cobalt fibres and their microwave properties. J Phys D: Appl Phys 33(22):2927–2930CrossRef

157.

Elumalai P, Vasan HN, Verelst M et al (2002) Synthesis and characterization of sub-micron size Co–Ni alloys using malonate as precursor. Mater Res Bull 37(2):353–363CrossRef

158.

Teranishi T, Miyake M (1999) Novel synthesis of monodispersed Pd/Ni nanoparticles. Chem Mater 11(12):3414–3416CrossRef

159.

Jézéquel D, Guenot J, Jouini N et al (1995) Submicrometer zinc oxide particles: elaboration in polyol medium and morphological characteristics. J Mater Res 10(1):77–83CrossRef

160.

Cai W, Wan J (2007) Facile synthesis of superparamagnetic magnetite nanoparticles in liquid polyols. J Colloid Interface Sci 305(2):366–370CrossRef

161.

Sra AK, Ewers TD, Schaak RE (2005) Direct solution synthesis of intermetallic AuCu and AuCu3 nanocrystals and nanowire networks. Chem Mater 17(4):758–766CrossRef

162.

Joseyphus RJ, Kodama D, Matsumoto T et al (2007) Role of polyol in the synthesis of Fe particles. J Magn Magn Mater 310(2, Part 3):2393–2395CrossRef

163.

Salazar-Alvarez G, Muhammed M, Zagorodni AA (2006) Novel flow injection synthesis of iron oxide nanoparticles with narrow size distribution. Chem Eng Sci 61(14):4625–4633CrossRef

164.

Pascal C, Pascal JL, Favier F et al (1999) Electrochemical synthesis for the control of γ-Fe2O3 nanoparticle size. Morphology, microstructure, and magnetic behavior. Chem Mater 11(1):141–147CrossRef

165.

Khan HR, Petrikowski K (2000) Anisotropic structural and magnetic properties of arrays of Fe26Ni74 nanowires electrodeposited in the pores of anodic alumina. J Magn Magn Mater 215–216:526–528CrossRef

166.

Fürstner A, editor (2008) Active metals: preparation, characterization, applications. John Wiley & Sons

167.

Pecharromán C, González-Carreño T, Iglesias JE (1995) The infrared dielectric properties of maghemite, γ-Fe2O3, from reflectance measurement on pressed powders. Phys Chem Minerals 22(1):21–29CrossRef

168.

González-Carreño T, Morales MP, Gracia M et al (1993) Preparation of uniform γ-Fe2O3 particles with nanometer size by spray pyrolysis. Mater Lett 18(3):151–155CrossRef

169.

Veintemillas-Verdaguer S, Morales MP, Serna CJ (1998) Continuous production of γ-Fe2O3 ultrafine powders by laser pyrolysis. Mater Lett 35(3):227–231CrossRef

170.

Morales MP, Bomati-Miguel O, Pérez de Alejo R et al (2003) Contrast agents for MRI based on iron oxide nanoparticles prepared by laser pyrolysis. J Magn Magn Mater 266(1):102–109CrossRef

171.

Veintemillas-Verdaguer S, Morales del Puerto M, Bomati-Miguel O et al (2004) Colloidal dispersions of maghemite nanoparticles produced by laser pyrolysis with application as NMR contrast agents. J Phys D: Appl Phys 37(15):2054–2059CrossRef

172.

Alexandrescu R, Morjan I, Voicu I et al (2005) Combining resonant/non-resonant processes: Nanometer-scale iron-based material preparation via CO2 laser pyrolysis. Appl Surf Sci 248(1):138–146CrossRef

173.

Julián-López B, Boissière C, Chanéac C et al (2007) Mesoporous maghemite–organosilica microspheres: a promising route towards multifunctional platforms for smart diagnosis and therapy. J Mater Chem 17(16):1563–1569CrossRef

174.

Osuna J, de Caro D, Amiens C et al (1996) Synthesis, characterization, and magnetic properties of cobalt nanoparticles from an organometallic precursor. J Phys Chem 100(35):14571–14574CrossRef

175.

Verelst M, Ely TO, Amiens C et al (1999) Synthesis and characterization of CoO, Co3O4, and mixed Co/CoO nanoparticules. Chem Mater 11(10):2702–2708CrossRef

176.

Dinega DP, Bawendi MG (1999) A solution-phase chemical approach to a new crystal structure of cobalt. Angew Chem Int Ed 38(12):1788–1791CrossRef

177.

Puntes VF, Krishnan KM, Alivisatos AP (2001) Colloidal nanocrystal shape and size control: the case of cobalt. Science 291(5511):2115–2117CrossRef

178.

Puntes VF, Krishnan K, Alivisatos AP (2002) Synthesis of colloidal cobalt nanoparticles with controlled size and shapes. Top Catal 19(2):145–148CrossRef

179.

Puntes VF, Krishnan KM, Alivisatos P (2001) Synthesis, self-assembly, and magnetic behavior of a two-dimensional superlattice of single-crystal ε-Co nanoparticles. Appl Phys Lett 78(15):2187–2189CrossRef

180.

Yin JS, Wang ZL (1997) Ordered self-assembling of tetrahedral oxide nanocrystals. Phys Rev Lett 79(13):2570–2573CrossRef

181.

Rotstein HG, Tannenbaum R (2002) Cluster coagulation and growth limited by surface interactions with polymers. J Phys Chem B 106(1):146–151CrossRef

182.

Ely TO, Amiens C, Chaudret B et al (1999) Synthesis of nickel nanoparticles. Influence of aggregation induced by modification of poly(vinylpyrrolidone) chain length on their magnetic properties. Chem Mater 11(3):526–529CrossRef

183.

Kataby G, Prozorov T, Koltypin Yu et al (1997) Self-assembled monolayer coatings on amorphous iron and iron oxide nanoparticles: thermal stability and chemical reactivity studies. Langmuir 13(23):6151–6158CrossRef

184.

Sidorov SN, Bronstein LM, Davankov VA et al (1999) Cobalt nanoparticle formation in the pores of hyper-cross-linked polystyrene: control of nanoparticle growth and morphology. Chem Mater 11(11):3210–3215CrossRef

185.

Park SJ, Kim S, Lee S et al (2000) Synthesis and magnetic studies of uniform iron nanorods and nanospheres. J Am Chem Soc 122(35):8581–8582CrossRef

186.

Abu Mukh-Qasem R, Gedanken A (2005) Sonochemical synthesis of stable hydrosol of Fe3O4 nanoparticles. J Colloid Interface Sci 284(2):489–494CrossRef

187.

Hee Kim E, Sook Lee H, Kook Kwak B et al (2005) Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent. J Magn Magn Mater 289:328–330CrossRef

188.

Suslick KS, Choe SB, Cichowlas AA et al (1991) Sonochemical synthesis of amorphous iron. Nature 353(6343):414–416CrossRef

189.

Suslick KS, Hyeon T, Fang M (1996) Nanostructured materials generated by high-intensity ultrasound: sonochemical synthesis and catalytic studies. Chem Mater 8(8):2172–2179CrossRef

190.

Suslick KS, Fang M, Hyeon T (1996) Sonochemical synthesis of iron colloids. J Am Chem Soc 118(47):11960–11961CrossRef

191.

Suslick KS, Hyeon T, Fang M et al (1995) Sonochemical synthesis of nanostructured catalysts. Mater Sci Eng, A 204(1):186–192CrossRef

192.

Bellissent R, Galli G, Hyeon T et al (1996) Magnetic and structural properties of amorphous transition metals and alloys. J Non-Cryst Solids 205–207:656–659CrossRef

193.

Shafi KVPM, Gedanken A, Goldfarb RB et al (1997) Sonochemical preparation of nanosized amorphous Fe-Ni alloys. J Appl Phys 81(10):6901–6905CrossRef

194.

Katabi G, Koltypin Yu, Cao X et al (1996) Self-assembled monolayer coatings of iron nanoparticles with thiol derivatives. J Cryst Growth 166(1):760–762CrossRef

195.

Ramesh S, Cohen Y, Aurbach D et al (1998) Atomic force microscopy investigation of the surface topography and adhesion of nickel nanoparticles to submicrospherical silica. Chem Phys Lett 287(3):461–467CrossRef

196.

Gibson CP, Putzer KJ (1995) Synthesis and characterization of anisometric cobalt nanoclusters. Science 267(5202):1338–1340CrossRef

197.

Koltypin Yu, Katabi G, Cao X et al (1996) Sonochemical preparation of amorphous nickel. J Non-Cryst Solids 201(1):159–162CrossRef

198.

Shafi KVPM, Gedanken A, Prozorov R (1998) Sonochemical preparation and characterization of nanosized amorphous Co–Ni alloy powders. J Mater Chem 8(3):769–773CrossRef

199.

Kataby G, Koltypin Y, Rothe J et al (1998) The adsorption of monolayer coatings on iron nanoparticles: Mössbauer spectroscopy and XANES results. Thin Solid Films 333(1):41–49CrossRef

200.

Shafi KVPM, Koltypin Y, Gedanken A et al (1997) Sonochemical preparation of nanosized amorphous NiFe2O4 particles. J Phys Chem B 101(33):6409–6414CrossRef

201.

Shafi KVPM, Ulman A, Yan X et al (2001) Sonochemical synthesis of functionalized amorphous iron oxide nanoparticles. Langmuir 17(16):5093–5097CrossRef

202.

Kumar RV, Koltypin Y, Cohen YS et al (2000) Preparation of amorphous magnetite nanoparticles embedded in polyvinyl alcohol using ultrasound radiation. J Mater Chem 10(5):1125–1129CrossRef

203.

Kumar RV, Diamant Y, Gedanken A (2000) Sonochemical synthesis and characterization of nanometer-size transition metal oxides from metal acetates. Chem Mater 12(8):2301–2305CrossRef

204.

Vijayakumar R, Koltypin Yu, Felner I et al (2000) Sonochemical synthesis and characterization of pure nanometer-sized Fe3O4 particles. Mater Sci Eng A 286(1):101–105CrossRef

205.

Paul KG, Frigo TB, Groman JY et al (2004) Synthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharides. Bioconjug Chem 15(2):394–401CrossRef

206.

Frank JA, Miller BR, Arbab AS et al (2003) Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228(2):480–487CrossRef

207.

Juang JH, Wang JJ, Shen CR et al (2010) Magnetic resonance imaging of transplanted mouse islets labeled with chitosan-coated superparamagnetic iron oxide nanoparticles. Transpl Proc 42(6):2104–2108CrossRef

208.

Bautista MC, Bomati-Miguel O, Zhao X et al (2004) Comparative study of ferrofluids based on dextran-coated iron oxide and metal nanoparticles for contrast agents in magnetic resonance imaging. Nanotechnology 15(4):S154–S159CrossRef

209.

Ahmad T, Bae H, Rhee I et al (2012) Particle size dependence of relaxivity for silica-coated iron oxide nanoparticles. Curr Appl Phys 12(3):969–974CrossRef

210.

Na HB, Song IC, Hyeon T (2009) Inorganic nanoparticles for MRI contrast agents. Adv Mater 21(21):2133–2148CrossRef

211.

Elfick APD, Green SM, McCaskie AW et al (2004) Opsonization of polyethylene wear particles regulates macrophage and osteoblast responses in vitro. J Biomed Mater Res Part B: Appl Biomater 71B(2):244–251CrossRef

212.

Saba TM, Di Luzio NR (1965) Kupffer cell phagocytosis and metabolism of a variety of particles as a function of opsonization. J Reticuloendothel Soc 2(5):437–453

213.

Rosensweig RE (2002) Heating magnetic fluid with alternating magnetic field. J Magn Magn Mater 252:370–374CrossRef

214.

Aruffo A, Stamenkovic I, Melnick M et al (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61(7):1303–1313CrossRef

215.

Assaraf YG, Brozovic A, Gonçalves AC et al (2019) The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resist Updates 46:100645CrossRef

216.

Barbault-Foucher S, Gref R, Russo P et al (2002) Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery. J Control Release 83(3):365–375CrossRef

217.

Vismara E, Bongio C, Coletti A et al (2017) Albumin and hyaluronic acid-coated superparamagnetic iron oxide nanoparticles loaded with paclitaxel for biomedical applications. Molecules 22(7):1030CrossRef

218.

Kim DK, Zhang Y, Kehr J et al (2001) Characterization and MRI study of surfactant-coated superparamagnetic nanoparticles administered into the rat brain. J Magn Magn Mater 225(1–2):256–261CrossRef

219.

Tamaura Y, Takahashi K, Kodera Y et al (1986) Chemical modification of lipase with ferromagnetic modifier ? A Ferromagnetic-modified lipase. Biotechnol Lett 8(12):877–880CrossRef

220.

Shultz MD, Calvin S, Fatouros PP et al (2007) Enhanced ferrite nanoparticles as MRI contrast agents. J Magn Magn Mater 311(1):464–468CrossRef

221.

Albornoz C, Jacobo SE (2006) Preparation of a biocompatible magnetic film from an aqueous ferrofluid. J Magn Magn Mater 305(1):12–15CrossRef

222.

Yokoi H, Kantoh T (1993) Thermal decomposition of the iron(III) hydroxide and magnetite composites of poly(vinyl alcohol). Preparation of magnetite and metallic iron particles. BCSJ 66(5):1536–1541CrossRef

223.

Sairam M, Naidu BVK, Nataraj SK et al (2006) Poly(vinyl alcohol)-iron oxide nanocomposite membranes for pervaporation dehydration of isopropanol, 1,4-dioxane and tetrahydrofuran. J Membr Sci 283(1–2):65–73CrossRef

224.

Schöpf B, Neuberger T, Schulze K et al (2005) Methodology description for detection of cellular uptake of PVA coated superparamagnetic iron oxide nanoparticles (SPION) in synovial cells of sheep. J Magn Magn Mater 293(1):411–418CrossRef

225.

Finotelli PV, Morales MA, Rocha-Leão MH et al (2004) Magnetic studies of iron(III) nanoparticles in alginate polymer for drug delivery applications. Mater Sci Eng, C 24(5):625–629CrossRef

226.

Butterworth MD, Illum L, Davis SS (2001) Preparation of ultrafine silica- and PEG-coated magnetite particles. Colloids Surf, A 179(1):93–102CrossRef

227.

Kohler N, Fryxell GE, Zhang M (2004) A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc 126(23):7206–7211CrossRef

228.

Velusamy P, Chia-Hung S, Shritama A et al (2016) Synthesis of oleic acid coated iron oxide nanoparticles and its role in anti-biofilm activity against clinical isolates of bacterial pathogens. J Taiwan Inst Chem Eng 59:450–456CrossRef

229.

Chang PR, Yu J, Ma X et al (2011) Polysaccharides as stabilizers for the synthesis of magnetic nanoparticles. Carbohyd Polym 83(2):640–644CrossRef

230.

Gaihre B, Khil MS, Lee DR et al (2009) Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study. Int J Pharm 365(1):180–189CrossRef

231.

Naha PC, Liu Y, Hwang G et al (2019) Dextran-coated iron oxide nanoparticles as biomimetic catalysts for localized and pH-activated biofilm disruption. ACS Nano 13(5):4960–4971CrossRef

232.

Tyukova IS, Safronov AP, Kotel’nikova AP et al (2014) Electrostatic and steric mechanisms of iron oxide nanoparticle sol stabilization by chitosan. Polym Sci Ser A 56(4):498–504CrossRef

233.

Khandhar AP, Keselman P, Kemp SJ et al (2017) Evaluation of PEG-coated iron oxide nanoparticles as blood pool tracers for preclinical magnetic particle imaging. Nanoscale 9(3):1299–1306CrossRef

234.

Walker M, Will I, Pratt A et al (2020) Magnetically triggered release of entrapped bioactive proteins from thermally responsive polymer-coated iron oxide nanoparticles for stem-cell proliferation. ACS Appl Nano Mater 3(6):5008–5013CrossRef

235.

Arsianti M, Lim M, Marquis CP et al (2010) Assembly of polyethylenimine-based magnetic iron oxide vectors: insights into gene delivery. Langmuir 26(10):7314–7326CrossRef

236.

Zhang M, O’Connor CJ (2007) Synthesis and characterization of PMMA coated magnetite nanocomposites by emulsion polymerization. MRS Online Proceedings Library (OPL) MRS Online Proceedings Library (OPL) (1032):1032–I14

237.

Padwal P, Bandyopadhyaya R, Mehra S (2014) Polyacrylic acid-coated iron oxide nanoparticles for targeting drug resistance in mycobacteria. Langmuir 30(50):15266–15276CrossRef

238.

Zhang Y, Du B, Wu Y et al (2022) Fe3O4@PDA@PEI core-shell microspheres as a novel magnetic sorbent for the rapid and broad-spectrum separation of bacteria in liquid phase. Materials 15(6):2039CrossRef

239.

Li GY, Jiang YR, Huang KL et al (2008) Preparation and properties of magnetic Fe3O4–chitosan nanoparticles. J Alloys Compounds 466(1):451–456CrossRef

240.

Amini-Fazl MS, Mohammadi R, Kheiri K (2019) 5-Fluorouracil loaded chitosan/polyacrylic acid/Fe3O4 magnetic nanocomposite hydrogel as a potential anticancer drug delivery system. Int J Biol Macromol 132:506–513CrossRef

241.

Bixner O, Kurzhals S, Virk M et al (2016) Triggered release from thermoresponsive polymersomes with superparamagnetic membranes. Materials 9(1):29CrossRef

242.

Shin JR, An GS, Choi SC (2021) Influence of carboxylic modification using polyacrylic acid on characteristics of Fe3O4 nanoparticles with cluster structure. Processes 9(10):1795CrossRef

243.

Sarkar S, Guibal E, Quignard F et al (2012) Polymer-supported metals and metal oxide nanoparticles: synthesis, characterization, and applications. J Nanopart Res 14(2):715CrossRef

244.

Seabra AB, Paula AJ, de Lima R et al (2014) Nanotoxicity of graphene and graphene oxide. Chem Res Toxicol 27(2):159–168CrossRef

245.

Bian Y, Bian ZY, Zhang JX et al (2015) Effect of the oxygen-containing functional group of graphene oxide on the aqueous cadmium ions removal. Appl Surf Sci 329:269–275CrossRef

246.

Gao P, Liu M, Tian J et al (2016) Improving the drug delivery characteristics of graphene oxide based polymer nanocomposites through the “one-pot” synthetic approach of single-electron-transfer living radical polymerization. Appl Surf Sci 378:22–29CrossRef

247.

Pei S, Cheng HM (2012) The reduction of graphene oxide. Carbon 50(9):3210–3228CrossRef

248.

Wang G, Shen X, Wang B et al (2009) Synthesis and characterisation of hydrophilic and organophilic graphene nanosheets. Carbon 47(5):1359–1364CrossRef

249.

Ayazi H, Akhavan O, Raoufi M et al (2020) Graphene aerogel nanoparticles for in-situ loading/pH sensitive releasing anticancer drugs. Colloids Surf, B 186:110712CrossRef

250.

Depan D, Shah J, Misra RDK (2011) Controlled release of drug from folate-decorated and graphene mediated drug delivery system: synthesis, loading efficiency, and drug release response. Mater Sci Eng, C 31(7):1305–1312CrossRef

251.

Ma D, Lin J, Chen Y et al (2012) In situ gelation and sustained release of an antitumor drug by graphene oxide nanosheets. Carbon 50(8):3001–3007CrossRef

252.

Konios D, Stylianakis MM, Stratakis E et al (2014) Dispersion behaviour of graphene oxide and reduced graphene oxide. J Colloid Interface Sci 430:108–112CrossRef

253.

Akhavan O, Ghaderi E (2010) Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano 4(10):5731–5736CrossRef

254.

Akhavan O, Ghaderi E, Akhavan A (2012) Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. Biomaterials 33(32):8017–8025CrossRef

255.

Wang Z, Liu CJ (2015) Preparation and application of iron oxide/graphene based composites for electrochemical energy storage and energy conversion devices: current status and perspective. Nano Energy 11:277–293CrossRef

256.

Li X, Zhu H, Feng J et al (2013) One-pot polylol synthesis of graphene decorated with size- and density-tunable Fe3O4 nanoparticles for porcine pancreatic lipase immobilization. Carbon 60:488–497CrossRef

257.

Baaziz W, Truong-Phuoc L, Duong-Viet C et al (2014) Few layer graphene decorated with homogeneous magnetic Fe3O4 nanoparticles with tunable covering densities. J Mater Chem A 2(8):2690CrossRef

258.

Pileni MP, Duxin N (2000) Micelle technology for magnetic nanosized alloys and composites. ChemTech 30(2):25–33

259.

Wagle DV, Rondinone AJ, Woodward JD et al (2017) Polyol synthesis of magnetite nanocrystals in a thermostable ionic liquid. Cryst Growth Des 17(4):1558–1567CrossRef

260.

Gupta AK, Wells S (2004) Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobiosci 3(1):66–73CrossRef

261.

Pileni MP (1993) Reverse micelles as microreactors. J Phys Chem 97(27):6961–6973CrossRef

262.

Alcalá MD, Real C (2006) Synthesis based on the wet impregnation method and characterization of iron and iron oxide-silica nanocomposites. Solid State Ionics 177(9):955–960CrossRef

263.

Gushikem Y, Rosatto SS (2001) Metal oxide thin films grafted on silica gel surfaces: recent advances on the analytical application of these materials. J Braz Chem Soc 12(6):695–705CrossRef

264.

Woo K, Hong J, Ahn JP (2005) Synthesis and surface modification of hydrophobic magnetite to processible magnetite@silica-propylamine. J Magn Magn Mater 293(1):177–181CrossRef

265.

van Ewijk GA, Vroege GJ, Philipse AP (1999) Convenient preparation methods for magnetic colloids. J Magn Magn Mater 201(1):31–33CrossRef

266.

Ma D, Guan J, Dénommée S et al (2006) Multifunctional nano-architecture for biomedical applications. Chem Mater 18(7):1920–1927CrossRef

267.

Lesnikovich AI, Shunkevich TM, Naumenko VN et al (1990) Dispersity of magnetite in magnetic liquids and the interaction with a surfactant. J Magn Magn Mater 85(1):14–16CrossRef

268.

Sun Y, Duan L, Guo Z et al (2005) An improved way to prepare superparamagnetic magnetite-silica core-shell nanoparticles for possible biological application. J Magn Magn Mater 285(1):65–70CrossRef

269.

Im SH, Herricks T, Lee YT et al (2005) Synthesis and characterization of monodisperse silica colloids loaded with superparamagnetic iron oxide nanoparticles. Chem Phys Lett 401(1):19–23CrossRef

270.

Xie L, Jiang R, Zhu F et al (2014) Application of functionalized magnetic nanoparticles in sample preparation. Anal Bioanal Chem 406(2):377–399CrossRef

271.

Yang HH, Zhang SQ, Chen XL et al (2004) Magnetite-containing spherical silica nanoparticles for biocatalysis and bioseparations. Anal Chem 76(5):1316–1321CrossRef

272.

Lyon JL, Fleming DA, Stone MB et al (2004) Synthesis of Fe oxide core/Au shell nanoparticles by iterative hydroxylamine seeding. Nano Lett 4(4):719–723CrossRef

273.

Lin J, Zhou W, Kumbhar A et al (2001) Gold-coated iron (Fe@Au) nanoparticles: synthesis, characterization, and magnetic field-induced self-assembly. J Solid State Chem 159(1):26–31CrossRef

274.

Kim J, Park S, Lee JE et al (2006) Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew Chem 118(46):7918–7922CrossRef

275.

Mekonnen TW, Birhan YS, Andrgie AT et al (2019) Encapsulation of gadolinium ferrite nanoparticle in generation 45 poly(amidoamine) dendrimer for cancer theranostics applications using low frequency alternating magnetic field. Colloids and Surfaces B: Biointerfaces 184:110531CrossRef

276.

Morawski AM, Winter PM, Crowder KC et al (2004) Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 51(3):480–486CrossRef

277.

Shepherd PG, Popplewell J, Charles SW (1970) A method of producing ferrofluid with gadolinium particles. J Phys D: Appl Phys 3(12):1985–1986CrossRef

278.

Xu HK, Sorensen CM, Klabunde KJ et al (1992) Aerosol synthesis of gadolinium iron garnet particles. J Mater Res 7(3):712–716CrossRef

279.

Arora HC, Jensen MP, Yuan Y et al (2012) Nanocarriers enhance doxorubicin uptake in drug-resistant ovarian cancer cells. Can Res 72(3):769–778CrossRef

280.

Fang C, Kievit FM, Veiseh O et al (2012) Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach. J Control Release 162(1):233–241CrossRef

281.

Munnier E, Cohen-Jonathan S, Linassier C et al (2008) Novel method of doxorubicin–SPION reversible association for magnetic drug targeting. Int J Pharm 363(1–2):170–176CrossRef

282.

Majeed MI, Lu Q, Yan W et al (2013) Highly water-soluble magnetic iron oxide (Fe3O4) nanoparticles for drug delivery: enhanced in vitro therapeutic efficacy of doxorubicin and MION conjugates. J Mater Chem B 1(22):2874CrossRef

283.

Kayal S, Ramanujan RV (2010) Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery. Mater Sci Eng, C 30(3):484–490CrossRef

284.

An GS, Chae DH, Hur JU et al (2018) Hollow-structured Fe3O4@SiO2 nanoparticles: novel synthesis and enhanced adsorbents for purification of plasmid DNA. Ceram Int 44(15):18791–18795CrossRef

285.

Lee HY, Lee SH, Xu C et al (2008) Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent. Nanotechnology 19(16):165101CrossRef

286.

Kopanja L, Kralj S, Zunic D et al (2016) Core–shell superparamagnetic iron oxide nanoparticle (SPION) clusters: TEM micrograph analysis, particle design and shape analysis. Ceram Int 42(9):10976–10984CrossRef

287.

Kumar A, Sharma G, Naushad M et al (2015) SPION/β-cyclodextrin core–shell nanostructures for oil spill remediation and organic pollutant removal from waste water. Chem Eng J 280:175–187CrossRef

288.

Wanna Y, Porntheerapat S, Pratontep S, Pui-ngam R et al (2016) Preparation and characterization of PEG bis(amine) grafted PMMA/SPION composite nanoparticles. Adv Mater Lett 7(3):176–80CrossRef

289.

Sharma G, Kumar A, Chauhan C et al (2017) Pectin-crosslinked-guar gum/SPION nanocomposite hydrogel for adsorption of m-cresol and o-chlorophenol. Sustain Chem Pharm 6:96–106CrossRef

290.

López J, González-Bahamón LF, Prado J et al (2012) Study of magnetic and structural properties of ferrofluids based on cobalt–zinc ferrite nanoparticles. J Magn Magn Mater 324(4):394–402CrossRef

291.

Vaidyanathan G, Sendhilnathan S, Arulmurugan R (2007) Structural and magnetic properties of Co1−xZnxFe2O4 nanoparticles by co-precipitation method. J Magn Magn Mater 313(2):293–299CrossRef

292.

Tajabadi M, Khosroshahi ME, Bonakdar S (2013) An efficient method of SPION synthesis coated with third generation PAMAM dendrimer. Colloids Surf, A 431:18–26CrossRef

293.

Sodipo BK, Aziz AA (2014) A sonochemical approach to the direct surface functionalization of superparamagnetic iron oxide nanoparticles with (3-aminopropyl)triethoxysilane. Beilstein J Nanotechnol 5:1472–1476CrossRef

294.

Unsoy G, Khodadust R, Yalcin S et al (2014) Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery. Eur J Pharm Sci 62:243–250CrossRef

295.

Ao L, Wang B, Liu P et al (2014) A folate-integrated magnetic polymer micelle for MRI and dual targeted drug delivery. Nanoscale 6(18):10710CrossRef

296.

Cheng J, Zheng Z, Tang W et al (2022) A new strategy for stem cells therapy for erectile dysfunction: adipose-derived stem cells transfect Neuregulin-1 gene through superparamagnetic iron oxide nanoparticles. Investig Clin Urol 63(3):359–367CrossRef

297.

Wang C, Zhang Z, Chen B et al (2018) Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system. J Colloid Interface Sci 516:332–341CrossRef

298.

Wang C, Huang J, Zhang Y et al (2021) Construction and evaluation of red blood cells-based drug delivery system for chemo-photothermal therapy. Colloids Surf, B 204:111789CrossRef

299.

Papadimitriou S, Bikiaris D (2009) Novel self-assembled core–shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release. J Control Release 138(2):177–184CrossRef

300.

Gautier J, Munnier E, Paillard A et al (2012) A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting. Int J Pharm 423(1):16–25CrossRef

301.

Zhang Q, Li W, Kong T et al (2013) Tailoring the interlayer interaction between doxorubicin-loaded graphene oxide nanosheets by controlling the drug content. Carbon 51:164–172CrossRef

302.

Chen L, Xue Y, Xia X et al (2015) A redox stimuli-responsive superparamagnetic nanogel with chemically anchored DOX for enhanced anticancer efficacy and low systemic adverse effects. J Mater Chem B 3(46):8949–8962CrossRef

303.

Liu Z, Sun X, Nakayama-Ratchford N et al (2007) Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 1(1):50–56CrossRef

304.

Sun X, Liu Z, Welsher K et al (2008) Nano-graphene oxide for cellular imaging and drug delivery. Nano Res 1(3):203–212CrossRef

305.

Liu L, Luo XB, Ding L et al (2019) Application of nanotechnology in the removal of heavy metal from water. Nanomaterials for the removal of pollutants and resource reutilization. Elsevier 83–147

306.

Ai L, Zhang C, Liao F et al (2011) Removal of methylene blue from aqueous solution with magnetite loaded multi-wall carbon nanotube: kinetic, isotherm and mechanism analysis. J Hazard Mater 198:282–290CrossRef

307.

Langmuir I (1918) The adsorption of gases on plane surfaces of glass, mica and platinum. J Am Chem Soc 40(9):1361–1403CrossRef

308.

Başar CA (2006) Applicability of the various adsorption models of three dyes adsorption onto activated carbon prepared waste apricot. J Hazard Mater 135(1):232–241CrossRef

309.

Bayazit ŞS (2014) Magnetic multi-wall carbon nanotubes for methyl orange removal from aqueous solutions: equilibrium, kinetic and thermodynamic studies. Sep Sci Technol 49(9):1389–1400CrossRef

310.

Ghaedi M, Haghdoust S, Kokhdan SN et al (2012) Comparison of activated carbon, multiwalled carbon nanotubes, and cadmium hydroxide nanowire loaded on activated carbon as adsorbents for kinetic and equilibrium study of removal of safranine O. Spectrosc Lett 45(7):500–510CrossRef

311.

Zhou X (2020) Correction to the calculation of Polanyi potential from Dubinnin-Rudushkevich equation. J Hazard Mater 384:121101CrossRef

312.

Hsieh CT, Teng H (2000) Langmuir and Dubinin-Radushkevich analyses on equilibrium adsorption of activated carbon fabrics in aqueous solutions. J Chem Technol Biotechnol 75(11):1066–1072CrossRef

313.

Chabani M, Amrane A, Bensmaili A (2006) Kinetic modelling of the adsorption of nitrates by ion exchange resin. Chem Eng J 125(2):111–117CrossRef

314.

Özcan A, Özcan AS, Tunali S et al (2005) Determination of the equilibrium, kinetic and thermodynamic parameters of adsorption of copper(II) ions onto seeds of Capsicum annuum. J Hazard Mater 124(1):200–208CrossRef

315.

Helfferich FG (1995) Ion exchange. Courier Corporation 642

316.

Onyango MS, Kojima Y, Aoyi O et al (2004) Adsorption equilibrium modeling and solution chemistry dependence of fluoride removal from water by trivalent-cation-exchanged zeolite F-9. J Colloid Interface Sci 279(2):341–350CrossRef

317.

Sheha RR, Metwally E (2007) Equilibrium isotherm modeling of cesium adsorption onto magnetic materials. J Hazard Mater 143(1):354–361CrossRef

318.

Amin NK (2009) Removal of direct blue-106 dye from aqueous solution using new activated carbons developed from pomegranate peel: adsorption equilibrium and kinetics. J Hazard Mater 165(1):52–62CrossRef

319.

Ghaedi M, Sadeghian B, Pebdani AA et al (2012) Kinetics, thermodynamics and equilibrium evaluation of direct yellow 12 removal by adsorption onto silver nanoparticles loaded activated carbon. Chem Eng J 187:133–141CrossRef

320.

Ertugay M, Certel M, Gurses A (2000) Moisture adsorption isotherms of Tarhana at 25 oC and 35 oC and the investigation of fitness of various isotherm equations to moisture sorption data of Tarhana. J Sci Food Agric 80(14):2001–2004CrossRef

321.

Weber WJ, Morris JC (1963) Kinetics of adsorption on carbon from solution. J Sanit Eng Div 89(2):31–59CrossRef

322.

Chien SH, Clayton WR (1980) Application of Elovich equation to the kinetics of phosphate release and sorption in soils. Soil Sci Soc Am J 44(2):265–268CrossRef

323.

Yao Y, Xu F, Chen M et al (2010) Adsorption behavior of methylene blue on carbon nanotubes. Biores Technol 101(9):3040–3046CrossRef

324.

Sharma P, Kaur R, Baskar C et al (2010) Removal of methylene blue from aqueous waste using rice husk and rice husk ash. Desalination 259(1):249–257CrossRef

325.

Karaer H, Kaya İ (2016) Synthesis, characterization of magnetic chitosan/active charcoal composite and using at the adsorption of methylene blue and reactive blue4. Microporous Mesoporous Mater 232:26–38CrossRef

326.

Boyd GE, Adamson AW, Myers LS (1947) The exchange adsorption of ions from aqueous solutions by organic zeolites. II. Kinetics 1. J Am Chem Soc 69(11):2836–48CrossRef

327.

Hameed BH, El-Khaiary MI (2008) Malachite green adsorption by rattan sawdust: Isotherm, kinetic and mechanism modeling. J Hazard Mater 159(2):574–579CrossRef

328.

Srivastava V, Weng CH, Singh VK et al (2011) Adsorption of nickel ions from aqueous solutions by nano alumina: kinetic, mass transfer, and equilibrium studies. J Chem Eng Data 56(4):1414–1422CrossRef

329.

Hasan M, Ahmad AL, Hameed BH (2008) Adsorption of reactive dye onto cross-linked chitosan/oil palm ash composite beads. Chem Eng J 136(2):164–172CrossRef

330.

Zhang H, Xue Y, Huang J et al (2015) Tailor-made magnetic nanocarriers with pH-induced charge reversal and pH-responsiveness to guide subcellular release of doxorubicin. J Mater Sci 50(6):2429–2442CrossRef

331.

He X, Wu X, Cai X et al (2012) Functionalization of magnetic nanoparticles with dendritic–linear–brush-like triblock copolymers and their drug release properties. Langmuir 28(32):11929–11938CrossRef

332.

Zhu L, Wang D, Wei X et al (2013) Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging. J Control Release 169(3):228–238CrossRef

333.

Guo X, Xue L, Lv W et al (2015) Facile synthesis of magnetic carboxymethylcellulose nanocarriers for pH-responsive delivery of doxorubicin. New J Chem 39(9):7340–7347CrossRef

334.

Chang Y, Liu N, Chen L et al (2012) Synthesis and characterization of DOX-conjugated dendrimer-modified magnetic iron oxide conjugates for magnetic resonance imaging, targeting, and drug delivery. J Mater Chem 22(19):9594–9601CrossRef

335.

Mu B, Liu P, Dong Y et al (2010) Superparamagnetic pH-sensitive multilayer hybrid hollow microspheres for targeted controlled release. J Polym Sci, Part A: Polym Chem 48(14):3135–3144CrossRef

336.

Du P, Zeng J, Mu B et al (2013) Biocompatible magnetic and molecular dual-targeting polyelectrolyte hybrid hollow microspheres for controlled drug release. Mol Pharmaceutics 10(5):1705–1715CrossRef

337.

Yang HY, Jang MS, Gao GH et al (2016) pH-Responsive biodegradable polymeric micelles with anchors to interface magnetic nanoparticles for MR imaging in detection of cerebral ischemic area. Nanoscale 8(25):12588–12598CrossRef

338.

Li X, Zeng D, Ke P et al (2020) Synthesis and characterization of magnetic chitosan microspheres for drug delivery. RSC Adv 10(12):7163–7169CrossRef

339.

Marcelo G, Muñoz-Bonilla A, Rodríguez-Hernández J et al (2013) Hybrid materials achieved by polypeptide grafted magnetite nanoparticles through a dopamine biomimetic surface anchored initiator. Polym Chem 4(3):558–567CrossRef

340.

Gamcsik MP, Kasibhatla MS, Teeter SD et al (2012) Glutathione levels in human tumors. Biomarkers 17(8):671–691CrossRef

341.

Tang Z, Zhang L, Wang Y et al (2016) Redox-responsive star-shaped magnetic micelles with active-targeted and magnetic-guided functions for cancer therapy. Acta Biomater 42:232–246CrossRef

342.

Matsumoto A, Cabral H, Sato N et al (2010) Assessment of tumor metastasis by the direct determination of cell-membrane sialic acid expression. Angew Chem 122(32):5626–5629CrossRef

343.

Ding M, Zeng X, He X et al (2014) Cell internalizable and intracellularly degradable cationic polyurethane micelles as a potential platform for efficient imaging and drug delivery. Biomacromol 15(8):2896–2906CrossRef

344.

Xu H, Zeiger BW, Suslick KS (2013) Sonochemical synthesis of nanomaterials. Chem Soc Rev 42(7):2555–2567CrossRef

345.

Xu F, Zhao T, Wang S et al (2016) Preparation of magnetic and pH-responsive chitosan microcapsules via sonochemical method. J Microencapsul 33(2):191–198CrossRef

346.

Xu F, Zhao T, Yang T et al (2016) Fabrication of folic acid functionalized pH-responsive and thermosensitive magnetic chitosan microcapsules via a simple sonochemical method. Colloids Surf, A 490:22–29CrossRef

347.

Cui X, Guan X, Zhong S et al (2017) Multi-stimuli responsive smart chitosan-based microcapsules for targeted drug delivery and triggered drug release. Ultrason Sonochem 38:145–153CrossRef

348.

Yang HY, Jang MS, Li Y et al (2017) Multifunctional and redox-responsive self-assembled magnetic nanovectors for protein delivery and dual-modal imaging. ACS Appl Mater Interfaces 9(22):19184–19192CrossRef

349.

Huang RY, Chiang PH, Hsiao WC et al (2015) Redox-sensitive polymer/SPIO nanocomplexes for efficient magnetofection and MR imaging of human cancer cells. Langmuir 31(23):6523–6531CrossRef

350.

Peng S, Wang QY, Xiao X et al (2020) Redox-responsive polyethyleneimine-coated magnetic iron oxide nanoparticles for controllable gene delivery and magnetic resonance imaging. Polym Int 69(2):206–214CrossRef

351.

Nelson AR, Fingleton B, Rothenberg ML et al (2000) Matrix metalloproteinases: biologic activity and clinical implications. JCO 18(5):1135–1135CrossRef

352.

Stern R (2008) Hyaluronidases in cancer biology. In Hyaluronan in cancer biology. Academic Press 207–220

353.

Götte M, Yip GW (2006) Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Can Res 66(21):10233–10237CrossRef

354.

Deng L, Wang G, Ren J et al (2012) Enzymatically triggered multifunctional delivery system based on hyaluronic acid micelles. RSC Adv 2(33):12909–12914CrossRef

355.

Kang T, Li F, Baik S et al (2017) Surface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapy. Biomaterials 136:98–114CrossRef

356.

Liu R, Fraylich M, Saunders BR (2009) Thermoresponsive copolymers: from fundamental studies to applications. Colloid Polym Sci 287(6):627–643CrossRef

357.

Chen S, Li Y, Guo C et al (2007) Temperature-responsive magnetite/PEO−PPO−PEO block copolymer nanoparticles for controlled drug targeting delivery. Langmuir 23(25):12669–12676CrossRef

358.

Wadajkar AS, Menon JU, Tsai YS et al (2013) Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles. Biomaterials 34(14):3618–3625CrossRef

359.

Heidarinasab A, Ahmad Panahi H, Faramarzi M et al (2016) Synthesis of thermosensitive magnetic nanocarrier for controlled sorafenib delivery. Mater Sci Eng, C 67:42–50CrossRef

360.

Peralta ME, Jadhav SA, Magnacca G et al (2019) Synthesis and in vitro testing of thermoresponsive polymer-grafted core-shell magnetic mesoporous silica nanoparticles for efficient controlled and targeted drug delivery. J Colloid Interface Sci 544:198–205CrossRef

361.

Ferjaoui Z, Jamal Al Dine E, Kulmukhamedova A et al (2019) Doxorubicin-loaded thermoresponsive superparamagnetic nanocarriers for controlled drug delivery and magnetic hyperthermia applications. ACS Appl Mater Interfaces 11(34):30610–30620CrossRef

362.

Aqil A, Vasseur S, Duguet E et al (2008) Magnetic nanoparticles coated by temperature responsive copolymers for hyperthermia. J Mater Chem 18(28):3352–3360CrossRef

363.

Talelli M, Rijcken CJF, Lammers T et al (2009) Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. Langmuir 25(4):2060–2067CrossRef

364.

Mai BT, Balakrishnan PB, Barthel MJ et al (2019) Thermoresponsive iron oxide nanocubes for an effective clinical translation of magnetic hyperthermia and heat-mediated chemotherapy. ACS Appl Mater Interfaces 11(6):5727–5739CrossRef

365.

Borlido L, Moura L, Azevedo AM et al (2013) Stimuli-responsive magnetic nanoparticles for monoclonal antibody purification. Biotechnol J 8(6):709–717CrossRef

366.

Shamim N, Hong L, Hidajat K et al (2006) Thermosensitive-polymer-coated magnetic nanoparticles: adsorption and desorption of Bovine Serum Albumin. J Colloid Interface Sci 304(1):1–8CrossRef

367.

Paulus AS, Heinzler R, Ooi HW et al (2015) Temperature-switchable agglomeration of magnetic particles designed for continuous separation processes in biotechnology. ACS Appl Mater Interfaces 7(26):14279–14287CrossRef

368.

Nagaoka H, Sato Y, Xie X et al (2011) Coupling stimuli-responsive magnetic nanoparticles with antibody–antigen detection in immunoassays. Anal Chem 83(24):9197–9200CrossRef

369.

Jauregui R, Srinivasan S, Vojtech LN et al (2018) Temperature-responsive magnetic nanoparticles for enabling affinity separation of extracellular vesicles. ACS Appl Mater Interfaces 10(40):33847–33856CrossRef

370.

Krishnan BP, Prieto-López LO, Hoefgen S et al (2020) Thermomagneto-responsive smart biocatalysts for malonyl-coenzyme a aynthesis. ACS Appl Mater Interfaces 12(18):20982–20990CrossRef

371.

Zhu K, Deng Z, Liu G et al (2017) Photoregulated cross-linking of superparamagnetic iron oxide nanoparticle (SPION) loaded hybrid nanovectors with synergistic drug release and magnetic resonance (MR) imaging enhancement. Macromolecules 50(3):1113–1125CrossRef

372.

Phan TTV, Bharathiraja S, Nguyen VT et al (2017) Polypyrrole–methylene blue nanoparticles as a single multifunctional nanoplatform for near-infrared photo-induced therapy and photoacoustic imaging. RSC Adv 7(56):35027–35037CrossRef

373.

Sahoo B, Devi KSP, Banerjee R et al (2013) Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug. ACS Appl Mater Interfaces 5(9):3884–3893CrossRef

374.

Sundaresan V, Menon JU, Rahimi M et al (2014) Dual-responsive polymer-coated iron oxide nanoparticles for drug delivery and imaging applications. Int J Pharm 466(1):1–7CrossRef

375.

Panahi HA, Tavanaei Y, Moniri E et al (2014) Synthesis and characterization of poly[N-isopropylacrylamide-co-1-(N, N-bis-carboxymethyl)amino-3-allylglycerol] grafted to magnetic nano-particles for the extraction and determination of fluvoxamine in biological and pharmaceutical samples. J Chromatogr A 1345:37–42CrossRef

376.

Bhattacharya D, Behera B, Kumar Sahu S et al (2016) Design of dual stimuli responsive polymer modified magnetic nanoparticles for targeted anti-cancer drug delivery and enhanced MR imaging. New J Chem 40(1):545–557CrossRef

377.

DuttaParidaMaiti SSC et al (2016) Polymer grafted magnetic nanoparticles for delivery of anticancer drug at lower pH and elevated temperature. J Colloid Interface Sci 467:70–80CrossRef

378.

Hervault A, Dunn AE, Lim M et al (2016) Doxorubicin loaded dual pH- and thermo-responsive magnetic nanocarrier for combined magnetic hyperthermia and targeted controlled drug delivery applications. Nanoscale 8(24):12152–61CrossRef

379.

Ghamkhari A, Ghorbani M, Aghbolaghi S (2018) A perfect stimuli-responsive magnetic nanocomposite for intracellular delivery of doxorubicin. Artific Cells, Nanomedid3e, and Biotechnology 46(sup3):S911–S921CrossRef

380.

Majewski AP, Schallon A, Jérôme V et al (2012) Dual-responsive magnetic core–shell nanoparticles for nonviral gene delivery and cell separation. Biomacromol 13(3):857–866CrossRef

381.

Zhou X, Wang L, Xu Y et al (2018) A pH and magnetic dual-response hydrogel for synergistic chemo-magnetic hyperthermia tumor therapy. RSC Adv 8(18):9812–9821CrossRef

382.

Ling D, ParkPark WSJ et al (2014) Multifunctional tumor pH-sensitive self-assembled nanoparticles for bimodal imaging and treatment of resistant heterogeneous tumors. J Am Chem Soc 136(15):5647–5655CrossRef

383.

Zou H, Yuan W (2014) Temperature- and redox-responsive magnetic complex micelles for controlled drug release. J Mater Chem B 3(2):260–269CrossRef

384.

Zeng J, Du P, Liu L et al (2015) Superparamagnetic reduction/pH/temperature multistimuli-responsive nanoparticles for targeted and controlled antitumor drug delivery. Mol Pharmaceutics 12(12):4188–4199CrossRef

385.

Vyas D, Lopez-Hisijos N, Gandhi S et al (2015) Doxorubicin-hyaluronan conjugated super-paramagnetic iron oxide nanoparticles (DOX-HA-SPION) enhanced cytoplasmic uptake of doxorubicin and modulated apoptosis, IL-6 release and NF-kappaB activity in human MDA-MB-231 breast cancer cells. Journal of nanoscience and nanotechnology 15(9):6413–22CrossRef

386.

Nosrati R, Abnous K, Alibolandi M et al (2021) Targeted SPION siderophore conjugate loaded with doxorubicin as a theranostic agent for imaging and treatment of colon carcinoma. Sci Rep 11(1):13065CrossRef

387.

Yar Y, Khodadust R, Akkoc Y et al (2018) Development of tailored SPION-PNIPAM nanoparticles by ATRP for dually responsive doxorubicin delivery and MR imaging. J Mater Chem B 6(2):289–300CrossRef

388.

Xue W, Liu XL, Ma H et al (2018) AMF responsive DOX-loaded magnetic microspheres: transmembrane drug release mechanism and multimodality postsurgical treatment of breast cancer. J Mater Chem B 6(15):2289–2303CrossRef

389.

Yang HM, Oh BC, Kim JH et al (2011) Multifunctional poly(aspartic acid) nanoparticles containing iron oxide nanocrystals and doxorubicin for simultaneous cancer diagnosis and therapy. Colloids Surf, A 391(1–3):208–215CrossRef

390.

Chen J, Shi M, Liu P et al (2014) Reducible polyamidoamine-magnetic iron oxide self-assembled nanoparticles for doxorubicin delivery. Biomaterials 35(4):1240–1248CrossRef

391.

Huang L, Ao L, Wang W et al (2015) Multifunctional magnetic silica nanotubes for MR imaging and targeted drug delivery. Chemical Communications 51(18):3923–3926CrossRef

392.

Peng N, Wu B, Wang L et al (2016) High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy. Biomater Sci 4(12):1802–1813CrossRef

393.

Rudge SR, Kurtz TL, Vessely CR et al (2000) Preparation, characterization, and performance of magnetic iron–carbon composite microparticles for chemotherapy. Biomaterials 21(14):1411–1420CrossRef

394.

Jain TK, Morales MA, Sahoo SK et al (2005) Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharmaceutics 2(3):194–205CrossRef

395.

Ma WF, Wu KY, Tang J et al (2012) Magnetic drug carrier with a smart pH-responsive polymer network shell for controlled delivery of doxorubicin. J Mater Chem 22(30):15206CrossRef

396.

Chiang WH, Huang WC, Chang CW et al (2013) Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging. J Control Release 168(3):280–288CrossRef

397.

Yang X, Wang Y, Huang X et al (2011) Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J Mater Chem 21(10):3448–3454CrossRef

398.

Guo Q, Jia, Yuan et al (2012) Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery. International journal of nanomedicine 1697–1708

399.

Zhu Y, Ikoma T, Hanagata N et al (2010) Rattle-type Fe ₃ O ₄ @SiO ₂ hollow mesoporous spheres as carriers for drug delivery. Small 6(3):471–478CrossRef

400.

Natu MV, de Sousa HC, Gil MH (2010) Effects of drug solubility, state and loading on controlled release in bicomponent electrospun fibers. Int J Pharm 397(1–2):50–58CrossRef

401.

Lin Z, Gao W, Hu H et al (2014) Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: high drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity. J Control Release 174:161–170CrossRef

402.

Benita S, Barkai A, Pathak YV (1990) Effect of drug loading extent on the in vitro release kinetic behaviour of nifedipine from polyacrylate microspheres. J Control Release 12(3):213–222CrossRef

403.

Decuzzi P, Ferrari M (2007) The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. Biomaterials 28(18):2915–2922CrossRef

404.

van Sluis R, Bhujwalla ZM, Raghunand N et al (1999) In vivo imaging of extracellular pH using1H MRSI. Magn Reson Med 41(4):743–750CrossRef

405.

Engin K, Leeper DB, Cater JR et al (1995) Extracellular pH distribution in human tumours. Int J Hyperth 11(2):211–216CrossRef

406.

DuDu JZXJ, Mao CQ et al (2011) Tailor-made dual pH-sensitive polymer–doxorubicin nanoparticles for efficient anticancer drug delivery. J Am Chem Soc 133(44):17560–17563CrossRef

407.

Sankaranarayanan J, Mahmoud EA, Kim G et al (2010) Multiresponse strategies to modulate burst degradation and release from nanoparticles. ACS Nano 4(10):5930–5936CrossRef

408.

Chen J, Qiu X, Ouyang J et al (2011) pH and reduction dual-sensitive copolymeric micelles for intracellular doxorubicin delivery. Biomacromol 12(10):3601–3611CrossRef

409.

Park JS, Han TH, Lee KY et al (2006) N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. J Control Release 115(1):37–45CrossRef

410.

Mellman I, Fuchs R, Helenius A (1986) Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 55(1):663–700CrossRef

411.

Sahu SK, Mallick SK, Santra S et al (2010) In vitro evaluation of folic acid modified carboxymethyl chitosan nanoparticles loaded with doxorubicin for targeted delivery. J Mater Sci: Mater Med 21(5):1587–1597

412.

El-Dakdouki MH, Xia J, Zhu DC et al (2014) Assessing the in vivo efficacy of doxorubicin loaded hyaluronan nanoparticles. ACS Appl Mater Interfaces 6(1):697–705CrossRef

413.

Iranpour S, Bahrami AR, Nekooei S et al (2021) Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy. J Nanobiotechnol 19(1):314CrossRef

414.

Bagheri E, Alibolandi M, Abnous K et al (2021) Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles. J Mater Chem B 9(5):1351–1363CrossRef

415.

Gautier J, Allard-Vannier E, Munnier E et al (2013) Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles. J Control Release 169(1):48–61CrossRef

416.

El-Dakdouki MH, Zhu DC, El-Boubbou K et al (2012) Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells. Biomacromol 13(4):1144–1151CrossRef

417.

Mahmoudi M, Simchi A, Imani M et al (2008) Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging. J Phys Chem B 112(46):14470–14481CrossRef

418.

Yu M, Huang S, Yu KJ et al (2012) Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. IJMS 13(5):5554–5570CrossRef

419.

Unger EC (2003) How can superparamagnetic iron oxides be used to monitor disease and treatment? Radiology 229(3):615–616CrossRef

420.

Cole AJ, David AE, Wang J et al (2011) Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials 32(8):2183–2193CrossRef

421.

Petros RA, DeSimone JM (2010) Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9(8):615–627CrossRef

422.

Hu SH, Liu TY, Liu DM et al (2007) Nano-ferrosponges for controlled drug release. J Control Release 121(3):181–189CrossRef

Springer Professional

Modifying superparamagnetic iron oxides nanoparticles for doxorubicin delivery carriers: a review

Abstract

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Premium Partner

Marktübersichten

Springer Professional

Abstract

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Weitere Artikel der Ausgabe 4/2023

New strategy to synthesis of hierarchical porous ZIF-8 for enhanced mass transport inside the pore

Fabrication of electrodes by deposition of lead clusters from the Matrix Assembly Cluster Source (MACS) into porous carbon paper for electrocatalysis

Linear correlation between electronegativity and adsorption energy of hydrated metal ions by carboxyl-functionalized single-walled carbon nanotubes

Modeling anisotropic mechanical properties and creep behavior of Ni()/Ni3Al() single crystal superalloys at high temperatures

Green synthesized magnetic nanoparticles for selective inhibition of osteosarcoma cancer

Formation of quasi-stable nanostructures from L-N-stearoyl glutamic acid and its dimethyl ester on solid surfaces

Premium Partner

Marktübersichten